Vanguard National Trust
BSX icon

Vanguard National Trust’s Boston Scientific BSX Stock Holding History

Vanguard National Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
417
+65
+18% +$3.53K ﹤0.01% 540
2026
Q1 		$22.1K Buy
+352
New +$28.2K ﹤0.01% 488

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard National Trust's BSX Position: Q2 2026 in Review

Vanguard National Trust increased its Boston Scientific (BSX) stake by 18% in Q2 2026, buying an estimated $3.53K and bringing the position to 417 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Vanguard National Trust first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $22.1K in Q1 2026. 1,461 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vanguard National Trust held 417 shares of Boston Scientific worth $17.8K as of Q2 2026.
  • Vanguard National Trust bought 65 Boston Scientific shares in Q2 2026, an estimated $3.53K.
  • Boston Scientific made up ﹤0.01% of Vanguard National Trust's portfolio in Q2 2026, its #540 holding.
  • Vanguard National Trust first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Vanguard National Trust's Boston Scientific position peaked at $22.1K in Q1 2026.
  • 1,461 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.